Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.

The Journal of urology - 1 Sept 2000

Eastham J A, Grafton W, Martin C M, Williams B J

Abstract excerpt

PURPOSE: Numerous advances have been made in gene therapy approaches for the treatment of solid tumors, including prostate cancer. While treatment of the primary tumor has been well investigated, little information is available regarding gene therapy techniques which might impact on the progression to metastatic disease. We investigate the ability of p53 adenovirus to suppress not only primary tumor growth, but...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenoviridae
Share to Antigens, Nuclear
Share to Chi-Square Distribution

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, ras

Share to Genetic Therapy

Share to Mice, Nude

Share to Neoplasm Metastasis

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 10953161
DOI: 10.1097/00005392-200009010-00055

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Suppression of primary tumor growth and the progression to metastasis with p53 adenovirus in human prostate cancer.PMID 10953161Read ↗

Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.Semantic proximity Read ↗

Oncolytic virotherapy for prostate cancer by E1A, E1B mutant adenovirus.Semantic proximity Read ↗

Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.Semantic proximity Read ↗

Suppression of tumor growth using a recombinant adenoviral vector carrying the dominant-negative mutant gene Survivin-D53A in a nude mice model.Semantic proximity Read ↗

A Dominant Role for p53-Dependent Cellular Senescence in Radiosensitization of Human Prostate Cancer CellsSemantic proximity Read ↗

p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3Semantic proximity Read ↗

Prostate derived factor in human prostate cancer cells: Gene induction by vitamin D via a p53‐dependent mechanism and inhibition of prostate cancer cell growthSemantic proximity Read ↗

Alterations of the P53 gene are associated with the progression of a human prostate carcinoma.Semantic proximity Read ↗

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma.Semantic proximity Read ↗

Androgen-independent growth of LNCaP prostate cancer cells is mediated by gain-of-function mutant p53.Semantic proximity Read ↗

MDM2 antagonists boost antitumor effect of androgen withdrawal: implications for therapy of prostate cancer.Semantic proximity Read ↗

p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.